Authors
Latest:
Growth Hormone Therapy Guidelines: Clinical and Managed Care PerspectivesCurrent treatment guidelines utilized by healthcare provider organizations and managed care organization insurance coverage policies for growth hormone therapy are reviewed.
Latest:
Oncology Biosimilars Bring Hope to Patients with CancerBiosimilars for rituximab, trastuzumab, and bevacizumab are currently approved for use in the European Union.
Latest:
Bispecifics, CAR T Cells Among Most Exciting Recent Advances in Hematologic MalignanciesExpert notes significant advances in the treatment of multiple myeloma, large B cell lymphomas, and acute myeloid leukemia, during a presentation at HOPA 2023 Annual Conference.
Latest:
ROUNDTABLE DISCUSSION: "THE FUTURE OF PHARMACY"Ms. Christopher is a freelance writer based in Portland, Ore.
Latest:
Utilizing the Stages of Change to Motivate PatientsHow can you engage patients to adapt healthy behaviors and be adherent? Motivational Interviewing may be the missing piece.
Latest:
Precision Medicine and the Pharmacist’s Role as a Trusted Counselor in Specialty PharmacyThe placement of clinical pharmacists at the nexus of functional pharmacogenomics and in specialty pharmacy care makes good sense.
Latest:
Making the Most of the ASHP MidyearThe editor of the Pharmacy Times Health-System Edition offers pointers on getting as much as you can out of the 2013 ASHP Midyear Clinical Meeting.
Latest:
Overcoming Barriers to Insulin TherapyPharmacists have an important role to play in dispelling myths about the use of insulin in effectively treating diabetes.
Latest:
Trends in Medication Utilization and the Cost of Treatment for GoutWith new drugs in the pipeline and the impact of updated FDA drug safety policies on colchicine, gout may no longer be inexpensive to treat.
Latest:
Community Pharmacist Shortage: Fact or Fiction?What is being done to address current and projected shortages of community pharmacists?
Latest:
Advanced Pharmacy Practice Rotation Experience During a Global PandemicCOVID-19 has not stolen my final year of pharmacy school from me, but rather, has given me once in lifetime learning opportunities unique to this time in my life and in the world.
Latest:
Specialty Pharmacy Improves Adherence to ImatinibThe authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.
Latest:
Exploring the Versatility of Azelaic Acid in Facial Acne, Truncal Acne, Photoaging, and MelasmaContinuing education activity featured in the March 2018 edition of Pharmacy Times.
Latest:
Neuropathic Pain: A Glimpse Inside the Unabating AfflictionOriginating from damage within nerve cells themselves, neuropathic pain is often complex, with many treatment challenges.
Latest:
Turning that Great Idea into a Thriving BusinessDo you have an entrepreneurial idea that could be commercialized? This article describes steps to take to develop your business plan.
Latest:
Driving Affordability, Patient Experience Across Practice SettingsMore than 25% of US patients have not filled a prescription or have reduced their prescribed dose because of high costs.
Latest:
Patient Understanding and Improved AdherenceMerck's Adherence Estimator survey can help health care professionals counsel patients more effectively.
Latest:
Lessons Learned: How Health-System Pharmacy Technicians Are Tackling COVID-19The California Board of Pharmacy has authorized multiple waivers of specific provisions of pharmacy law, several of which have had major implications for pharmacy technicians and their scope of practice.
Latest:
The New Paradigm: Capturing Value, Improving Access, and Maximizing OutcomesQuality measures generate vital information on outcomes and can help ensure that medications are used appropriately and effectively.
Latest:
The Role of Specialty Drugs in Private Sector Healthcare SpendingThis study characterizes the role of specialty drug utilization in aggregate private sector healthcare spending in the United States from 2000 to 2009.
Latest:
Private-payer Costs for Employees with Treatment-resistant DepressionIndividuals with treatment-resistant depression do not achieve and sustain remission after multiple pharmacotherapies, with an unknown impact on employment. This study investigates the expenditures of TRD from a private-payer perspective in Canada.
Latest:
Identification and Management of Recurrent C Difficile InfectionShared insight on the prevalence of recurring Clostridioides difficile infection and management strategies.
